S&P 500   3,953.27 (-0.26%)
DOW   33,647.17 (-0.40%)
QQQ   284.26 (+0.14%)
AAPL   144.23 (+1.11%)
MSFT   246.97 (-0.17%)
META   116.93 (+1.39%)
GOOGL   93.63 (-0.09%)
AMZN   89.46 (-0.99%)
TSLA   180.12 (+3.85%)
NVDA   172.99 (+0.76%)
NIO   12.85 (-4.18%)
BABA   92.35 (-1.93%)
AMD   69.64 (-1.18%)
T   19.20 (+0.42%)
MU   55.52 (+0.58%)
CGC   2.94 (-4.85%)
F   13.23 (+0.84%)
GE   82.26 (-1.64%)
DIS   94.13 (+1.71%)
AMC   5.84 (-3.79%)
PYPL   74.18 (-0.05%)
PFE   51.90 (+0.23%)
NFLX   325.08 (+4.78%)
S&P 500   3,953.27 (-0.26%)
DOW   33,647.17 (-0.40%)
QQQ   284.26 (+0.14%)
AAPL   144.23 (+1.11%)
MSFT   246.97 (-0.17%)
META   116.93 (+1.39%)
GOOGL   93.63 (-0.09%)
AMZN   89.46 (-0.99%)
TSLA   180.12 (+3.85%)
NVDA   172.99 (+0.76%)
NIO   12.85 (-4.18%)
BABA   92.35 (-1.93%)
AMD   69.64 (-1.18%)
T   19.20 (+0.42%)
MU   55.52 (+0.58%)
CGC   2.94 (-4.85%)
F   13.23 (+0.84%)
GE   82.26 (-1.64%)
DIS   94.13 (+1.71%)
AMC   5.84 (-3.79%)
PYPL   74.18 (-0.05%)
PFE   51.90 (+0.23%)
NFLX   325.08 (+4.78%)
S&P 500   3,953.27 (-0.26%)
DOW   33,647.17 (-0.40%)
QQQ   284.26 (+0.14%)
AAPL   144.23 (+1.11%)
MSFT   246.97 (-0.17%)
META   116.93 (+1.39%)
GOOGL   93.63 (-0.09%)
AMZN   89.46 (-0.99%)
TSLA   180.12 (+3.85%)
NVDA   172.99 (+0.76%)
NIO   12.85 (-4.18%)
BABA   92.35 (-1.93%)
AMD   69.64 (-1.18%)
T   19.20 (+0.42%)
MU   55.52 (+0.58%)
CGC   2.94 (-4.85%)
F   13.23 (+0.84%)
GE   82.26 (-1.64%)
DIS   94.13 (+1.71%)
AMC   5.84 (-3.79%)
PYPL   74.18 (-0.05%)
PFE   51.90 (+0.23%)
NFLX   325.08 (+4.78%)
S&P 500   3,953.27 (-0.26%)
DOW   33,647.17 (-0.40%)
QQQ   284.26 (+0.14%)
AAPL   144.23 (+1.11%)
MSFT   246.97 (-0.17%)
META   116.93 (+1.39%)
GOOGL   93.63 (-0.09%)
AMZN   89.46 (-0.99%)
TSLA   180.12 (+3.85%)
NVDA   172.99 (+0.76%)
NIO   12.85 (-4.18%)
BABA   92.35 (-1.93%)
AMD   69.64 (-1.18%)
T   19.20 (+0.42%)
MU   55.52 (+0.58%)
CGC   2.94 (-4.85%)
F   13.23 (+0.84%)
GE   82.26 (-1.64%)
DIS   94.13 (+1.71%)
AMC   5.84 (-3.79%)
PYPL   74.18 (-0.05%)
PFE   51.90 (+0.23%)
NFLX   325.08 (+4.78%)
NYSE:NUS

Nu Skin Enterprises - NUS Price Target & Analyst Ratings

$40.17
-0.35 (-0.86%)
(As of 12/9/2022 01:57 PM ET)
Add
Compare
Today's Range
$40.13
$40.89
50-Day Range
$31.79
$42.45
52-Week Range
$29.95
$56.76
Volume
19,570 shs
Average Volume
1.03 million shs
Market Capitalization
$1.99 billion
P/E Ratio
54.28
Dividend Yield
3.76%
Price Target
$48.00

Nu Skin Enterprises Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 2 Analyst Ratings

Consensus Analyst Price Target

$48.00
19.49% Upside
High Prediction$75.00
Average Prediction$48.00
Low Prediction$34.00
TypeCurrent
12/9/21 to 12/9/22
1 Month Ago
11/9/21 to 11/9/22
3 Months Ago
9/10/21 to 9/10/22
1 Year Ago
12/9/20 to 12/9/21
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$48.00$50.00$58.50$59.60
Predicted Upside19.49% Upside18.26% Upside29.87% Upside24.02% Upside
Get Nu Skin Enterprises Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter.


NUS Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NUS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Nu Skin Enterprises Stock vs. The Competition

TypeNu Skin EnterprisesConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.00
2.48
2.48
Consensus RatingHoldHoldHold
Predicted Upside18.46% Upside182.00% Upside14.86% Upside
News Sentiment RatingPositive News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
508
65.89%
Underperform Votes
263
34.11%
Avg. Outperform Votes
232
60.89%
Avg. Underperform Votes
149
39.11%
Avg. Outperform Votes
853
68.13%
Avg. Underperform Votes
399
31.87%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/23/2022DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$40.00 ➝ $34.00-13.62%
11/4/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$39.00 ➝ $35.00+10.10%
2/17/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$61.00 ➝ $75.00+33.86%
10/1/2021Tigress Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ivan Feinseth
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$72.00+73.58%
5/6/2021Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold$57.00 ➝ $64.00+19.85%
10/2/2020Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral$54.00 ➝ $58.00+13.33%
8/6/2020Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold$50.00 ➝ $55.00+17.75%
(Data available from 12/9/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












NUS Price Target - Frequently Asked Questions

What is Nu Skin Enterprises's consensus rating and price target?

According to the issued ratings of 2 analysts in the last year, the consensus rating for Nu Skin Enterprises stock is Hold based on the current 2 hold ratings for NUS. The average twelve-month price prediction for Nu Skin Enterprises is $48.00 with a high price target of $75.00 and a low price target of $34.00. Learn more on NUS's analyst rating history.

Do Wall Street analysts like Nu Skin Enterprises more than its competitors?

Analysts like Nu Skin Enterprises less than other Consumer Staples companies. The consensus rating score for Nu Skin Enterprises is 2.00 while the average consensus rating score for consumer staples companies is 2.48. Learn more on how NUS compares to other companies.

Do MarketBeat users like Nu Skin Enterprises more than its competitors?

MarketBeat users like Nu Skin Enterprises more than other Consumer Staples companies. 65.89% of MarketBeat users gave Nu Skin Enterprises an outperform vote while consumer staples companies recieve an average of 60.89% outperform votes by MarketBeat users.

Does Nu Skin Enterprises's stock price have much upside?

According to analysts, Nu Skin Enterprises's stock has a predicted upside of 18.58% based on their 12-month price targets.

What analysts cover Nu Skin Enterprises?

Nu Skin Enterprises has been rated by Citigroup, and DA Davidson in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:NUS) was last updated on 12/9/2022 by MarketBeat.com Staff